Mohamed Z Habib1, Mai A Ebeid2, Yasser El Faramawy3, Sherin S T Saad2, Hekmat M El Magdoub4, Azza A Attia5, Sawsan Aboul-Fotouh2, Ahmed M Abdel-Tawab2. 1. Department of Clinical Pharmacology, Faculty of Medicine, Ain Shams University, Cairo, Egypt. Electronic address: Mohamed.habib@med.asu.edu.eg. 2. Department of Clinical Pharmacology, Faculty of Medicine, Ain Shams University, Cairo, Egypt. 3. Department of Geriatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt. 4. Department of Biochemistry, Faculty of Pharmacy, Misr International University, Cairo, Egypt. 5. Department of Histology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Abstract
Microglial in vivo production of pro-inflammatory cytokines is central to the pathogenesis of multiple neurological disorders including depression, with a rising role of Wnt/β-catenin signaling as potential regulator of microglia-mediated neuro-inflammation. This study aimed at investigating the hippocampal expression of the Wnt/ß-catenin pathway in chronic mild stress (CMS)-exposed rats and the effects of Lithium (Li) on the expression of this pathway as a method to identify a plausible link between exposure to chronic stress, microglial activation, and neuroinflammation. METHODS: The effect of chronic administration of Li was investigated on behavioral changes, hippocampal expression of Wnt-DVL-GSK3β-β-catenin signaling pathway, and microglial activation in CMS-exposed male Wistar rats RESULTS: CMS induced a depressive-like behavior associated with increased pro-inflammatory microglial activation and reduced hippocampal expression of the Wnt/β-catenin signaling pathway. Chronic Li treatment ameliorated stress induced-behavioral changes, reduced microglial activation and enhanced the hippocampal expression of Wnt/β-catenin signaling pathway. CONCLUSION: This work highlights that Li-induced inhibition of GSK-3β with subsequent accumulation of β-catenin could impede pro-inflammatory microglia activation which is a key pathological hallmark associated with depression. Wnt/β-catenin signaling represents a promising therapeutic target, not only for alleviation of depression, but also for a wide array of neurological disorders.
Microglial in vivo production of pro-inflammatory cytokines is central to the pathogenesis of multiple neurological disorders including depression, with a rising role of Wnt/β-catenin signaling as potential regulator of microglia-mediated neuro-inflammation. This study aimed at investigating the hippocampal expression of the Wnt/ß-catenin pathway in chronic mild stress (CMS)-exposed rats and the effects of Lithium (Li) on the expression of this pathway as a method to identify a plausible link between exposure to chronic stress, microglial activation, and neuroinflammation. METHODS: The effect of chronic administration of Li was investigated on behavioral changes, hippocampal expression of Wnt-DVL-GSK3β-β-catenin signaling pathway, and microglial activation in CMS-exposed male Wistar rats RESULTS: CMS induced a depressive-like behavior associated with increased pro-inflammatory microglial activation and reduced hippocampal expression of the Wnt/β-catenin signaling pathway. Chronic Li treatment ameliorated stress induced-behavioral changes, reduced microglial activation and enhanced the hippocampal expression of Wnt/β-catenin signaling pathway. CONCLUSION: This work highlights that Li-induced inhibition of GSK-3β with subsequent accumulation of β-catenin could impede pro-inflammatory microglia activation which is a key pathological hallmark associated with depression. Wnt/β-catenin signaling represents a promising therapeutic target, not only for alleviation of depression, but also for a wide array of neurological disorders.
Authors: Elif Tunc-Ozcan; Sarah M Brooker; Jacqueline A Bonds; Yung-Hsu Tsai; Radhika Rawat; Tammy L McGuire; Chian-Yu Peng; John A Kessler Journal: Cell Mol Life Sci Date: 2021-12-22 Impact factor: 9.207
Authors: Dalia Abdelhafez; Elshimaa Aboelkomsan; Abir El Sadik; Noha Lasheen; Sara Ashur; Amal Elshimy; George N B Morcos Journal: J Diabetes Res Date: 2021-10-16 Impact factor: 4.011